Should Total Neoadjuvant Therapy Be the First-Line Treatment for Patients With Locally Advanced Rectal Cancer?

Mahsoem Ali; Lenka N.C. Boyd; Elisa Giovannetti; Geert Kazemier

doi:10.1200/jco-24-02080

Should Total Neoadjuvant Therapy Be the First-Line Treatment for Patients With Locally Advanced Rectal Cancer?

M Mahsoem Ali (Mahsoem Ali, BSc, and Lenka N.C. Boyd, MD, Amsterdam UMC, Location Vrije Universiteit, Department of Surgery, Amsterdam, the Netherlands, Amsterdam UMC, Location Vrije Universiteit, Department of Medical Oncology, Lab of Medical Oncology, Amsterdam, the Netherlands, Cancer Center Amsterdam, Imaging and Biomarkers, Amsterdam, the Netherlands; Elisa Giovannetti, MD PhD, Amsterdam UMC, Location Vrije Universiteit, Department of Medical Oncology, Lab of Medical Oncology, Amsterdam, the Netherlands;...) L Lenka N.C. Boyd (Mahsoem Ali, BSc, and Lenka N.C. Boyd, MD, Amsterdam UMC, Location Vrije Universiteit, Department of Surgery, Amsterdam, the Netherlands, Amsterdam UMC, Location Vrije Universiteit, Department of Medical Oncology, Lab of Medical Oncology, Amsterdam, the Netherlands, Cancer Center Amsterdam, Imaging and Biomarkers, Amsterdam, the Netherlands; Elisa Giovannetti, MD PhD, Amsterdam UMC, Location Vrije Universiteit, Department of Medical Oncology, Lab of Medical Oncology, Amsterdam, the Netherlands;...) E Elisa Giovannetti G Geert Kazemier (Department of Surgery, Location University of Amsterdam, Amsterdam UMC, Amsterdam, the Netherlands)

View Original

APA MLA Chicago BibTeX RIS

Article Details

Journal Journal of Clinical Oncology

Volume / Issue Vol. 43, Issue 8

Published March 10, 2025

Pages 1041-1043

DOI 10.1200/jco-24-02080

ISSN 0732-183X

Publisher Lippincott Williams & Wilkins

Journal Info

Journal of Clinical Oncology

Lippincott Williams & Wilkins

ISSN: 0732-183X Health Sciences

Authors (4)

M

Mahsoem Ali

Mahsoem Ali, BSc, and Lenka N.C. Boyd, MD, Amsterdam UMC, Location Vrije Universiteit, Department of Surgery, Amsterdam, the Netherlands, Amsterdam UMC, Location Vrije Universiteit, Department of Medical Oncology, Lab of Medical Oncology, Amsterdam, the Netherlands, Cancer Center Amsterdam, Imaging and Biomarkers, Amsterdam, the Netherlands; Elisa Giovannetti, MD PhD, Amsterdam UMC, Location Vrije Universiteit, Department of Medical Oncology, Lab of Medical Oncology, Amsterdam, the Netherlands;...

L

Lenka N.C. Boyd

Mahsoem Ali, BSc, and Lenka N.C. Boyd, MD, Amsterdam UMC, Location Vrije Universiteit, Department of Surgery, Amsterdam, the Netherlands, Amsterdam UMC, Location Vrije Universiteit, Department of Medical Oncology, Lab of Medical Oncology, Amsterdam, the Netherlands, Cancer Center Amsterdam, Imaging and Biomarkers, Amsterdam, the Netherlands; Elisa Giovannetti, MD PhD, Amsterdam UMC, Location Vrije Universiteit, Department of Medical Oncology, Lab of Medical Oncology, Amsterdam, the Netherlands;...

E

Elisa Giovannetti

G

Geert Kazemier

Department of Surgery, Location University of Amsterdam, Amsterdam UMC, Amsterdam, the Netherlands

Should Total Neoadjuvant Therapy Be the First-Line Treatment for Patients With Locally Advanced Rectal Cancer?

Article Details

Journal Info

Authors (4)

Related Articles from this Journal

Prostate-Specific Membrane Antigen Positron Emission Tomography and Radiometabolic Therapies in Metastatic Castration-Resistant Prostate Cancer

Allogeneic CD70-Targeted Chimeric Antigen Receptor T-Cell Therapy for Advanced Renal Cell Carcinoma: Results From the Phase I TRAVERSE Trial

Adjuvant Carboplatin for Early-Stage, Triple-Negative Breast Cancer: Taxane and Patient Selection

Erratum: All-Oral Combination of Revumenib, Decitabine, and Venetoclax for Relapsed or Refractory AML (SAVE)

Reply to: Prostate-Specific Membrane Antigen Positron Emission Tomography and Radiometabolic Therapies in Metastatic Castration-Resistant Prostate Cancer